GH Research Plc (GHRS)
28.09
-0.24
(-0.85%)
USD |
NASDAQ |
Aug 24, 16:00
28.09
0.00 (0.00%)
After-Hours: 20:00
GH Research 1 Year Total Returns (Daily) : 118.1% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 118.1% |
| August 20, 2026 | 124.4% |
| August 19, 2026 | 137.5% |
| August 18, 2026 | 134.7% |
| August 17, 2026 | 134.4% |
| August 14, 2026 | 130.8% |
| August 13, 2026 | 124.4% |
| August 12, 2026 | 149.1% |
| August 11, 2026 | 146.4% |
| August 10, 2026 | 138.0% |
| August 07, 2026 | 150.2% |
| August 06, 2026 | 152.2% |
| August 05, 2026 | 123.0% |
| August 04, 2026 | 116.7% |
| August 03, 2026 | 105.2% |
| July 31, 2026 | 95.47% |
| July 30, 2026 | 103.0% |
| July 29, 2026 | 86.91% |
| July 28, 2026 | 86.65% |
| July 27, 2026 | 91.38% |
| July 24, 2026 | 88.27% |
| July 23, 2026 | 94.03% |
| July 22, 2026 | 71.24% |
| July 21, 2026 | 45.38% |
| July 20, 2026 | 56.69% |
| Date | Value |
|---|---|
| July 17, 2026 | 66.43% |
| July 16, 2026 | 68.48% |
| July 15, 2026 | 68.36% |
| July 14, 2026 | 62.34% |
| July 13, 2026 | 59.74% |
| July 10, 2026 | 65.17% |
| July 09, 2026 | 75.71% |
| July 08, 2026 | 85.56% |
| July 07, 2026 | 79.21% |
| July 06, 2026 | 75.46% |
| July 02, 2026 | 79.71% |
| July 01, 2026 | 107.7% |
| June 30, 2026 | 120.5% |
| June 29, 2026 | 129.0% |
| June 26, 2026 | 127.6% |
| June 25, 2026 | 113.1% |
| June 24, 2026 | 96.17% |
| June 23, 2026 | 102.1% |
| June 22, 2026 | 79.45% |
| June 18, 2026 | 87.84% |
| June 17, 2026 | 80.98% |
| June 16, 2026 | 57.08% |
| June 15, 2026 | 59.64% |
| June 12, 2026 | 64.61% |
| June 11, 2026 | 49.82% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Atai Beckley, Inc. | 68.11% |
| Avadel Pharmaceuticals Plc | 46.02% |
| Jazz Pharmaceuticals Plc | 111.0% |
| Eli Lilly & Co. | 77.98% |
| Perrigo Co. Plc | -33.93% |